안녕하세요,

에스티팜에서 2020 Open Innovation Research Challenge 공모를 진행한다고 합니다.  mRNA의 cancer/viral disease 치료제 개발 관련 기초 연구과제를 다양한 연구진과 협업하고자 기획한 공모전이라고 하고 자세한 내용은 첨부된 파일을 참고하세요

ST Pharm is a subsidiary of Dong-A Socio Group in Korea. ST Pharm has an open innovative ‘Virtual R&D’ strategy pursuing first-in-class new drug development by collaborations with diverse academies, hospitals, and research institutes. Two clinical studies in Phase 1 are running in the US and Europe, and two IND-enabling projects and five R&D projects are moving forward to the next round.

As a new momentum, we’re initiating <Open Innovation Research Challenge> in the field of mRNA-based therapeutics to explore collaborations with a strategic partnership in the United States. Please check the attached files.